4D Molecular Therapeutics Inc (FDMT)
25.64
+0.06
(+0.23%)
USD |
NASDAQ |
May 16, 16:00
25.66
+0.02
(+0.08%)
After-Hours: 20:00
4D Molecular Therapeutics Enterprise Value: 799.76M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 799.76M |
| May 15, 2024 | 796.66M |
| May 14, 2024 | 805.45M |
| May 13, 2024 | 796.14M |
| May 10, 2024 | 802.87M |
| May 09, 2024 | 799.76M |
| May 08, 2024 | 835.44M |
| May 07, 2024 | 859.74M |
| May 06, 2024 | 857.67M |
| May 03, 2024 | 838.02M |
| May 02, 2024 | 823.62M |
| May 01, 2024 | 772.98M |
| April 30, 2024 | 698.29M |
| April 29, 2024 | 714.66M |
| April 26, 2024 | 663.50M |
| April 25, 2024 | 677.82M |
| April 24, 2024 | 714.66M |
| April 23, 2024 | 743.31M |
| April 22, 2024 | 824.14M |
| April 19, 2024 | 765.82M |
| April 18, 2024 | 741.77M |
| April 17, 2024 | 768.37M |
| April 16, 2024 | 842.55M |
| April 15, 2024 | 816.97M |
| April 12, 2024 | 822.09M |
| Date | Value |
|---|---|
| April 11, 2024 | 891.15M |
| April 10, 2024 | 851.76M |
| April 09, 2024 | 860.46M |
| April 08, 2024 | 944.87M |
| April 05, 2024 | 937.19M |
| April 04, 2024 | 888.08M |
| April 03, 2024 | 902.41M |
| April 02, 2024 | 905.47M |
| April 01, 2024 | 1.009B |
| March 31, 2024 | 1.104B |
| March 28, 2024 | 1.298B |
| March 27, 2024 | 1.497B |
| March 26, 2024 | 1.407B |
| March 25, 2024 | 1.384B |
| March 22, 2024 | 1.384B |
| March 21, 2024 | 1.394B |
| March 20, 2024 | 1.379B |
| March 19, 2024 | 1.306B |
| March 18, 2024 | 1.256B |
| March 15, 2024 | 1.280B |
| March 14, 2024 | 1.174B |
| March 13, 2024 | 1.175B |
| March 12, 2024 | 1.132B |
| March 11, 2024 | 1.133B |
| March 08, 2024 | 1.184B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-52.69M
Minimum
Jun 16 2022
1.497B
Maximum
Mar 27 2024
462.20M
Average
451.17M
Median
Enterprise Value Benchmarks
| Ionis Pharmaceuticals Inc | 4.560B |
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
| iBio Inc | 16.17M |
| Theriva Biologics Inc | -8.844M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.40M |
| Revenue (Quarterly) | 0.028M |
| Total Expenses (Quarterly) | 38.16M |
| EPS Diluted (Quarterly) | -0.66 |
| Profit Margin (Quarterly) | -115.7K% |
| Earnings Yield | -9.52% |
| Normalized Earnings Yield | -9.516 |